Picture of Genovis AB logo

GENO Genovis AB Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapFalling Star

Annual cashflow statement for Genovis AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line10.13.1424.58.2854.2
Depreciation
Non-Cash Items3.465.435.775.8810.1
Unusual Items
Other Non-Cash Items
Changes in Working Capital-3.9-4.8215.6-15.13.38
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities13.13.7645.9-0.92867.8
Capital Expenditures-5.15-20.4-4.49-3.83
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0-12.8
Other Investing Cash Flow
Cash from Investing Activities-5.15-20.4-4.49-3.83-12.8
Financing Cash Flow Items-2.56-4.51
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-2.5645.8-4.23-3.73-4.51
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash5.4129.137.2-8.4850.4